Abstract

Few settings have been as dramatically affected by the COVID-19 pandemic as jails and prisons across the United States. The majority of the largest national outbreaks of COVID-19 have taken place in carceral facilities with some reporting positive testing rates of over 70%, [1]. The FDA has granted emergency use authorization for two SARS-CoV-2 vaccines that demonstrate near 95% efficiency, offering a life-saving tool to prevent future infections and outbreaks. Vaccine allocation, particularly among incarcerated individuals, remains a controversial topic.

Highlights

  • Few settings have been as dramatically affected by the COVID19 pandemic as jails and prisons across the United States

  • There are very clear reasons why incarcerated people should be prioritized for vaccination efforts

  • Incarcerated individuals are at high risk for Covid-19 transmission and severe disease

Read more

Summary

Introduction

Few settings have been as dramatically affected by the COVID19 pandemic as jails and prisons across the United States. The FDA has granted emergency use authorization for two SARS-CoV-2 vaccines that demonstrate near 95% efficiency, offering a life-saving tool to prevent future infections and outbreaks. There are very clear reasons why incarcerated people should be prioritized for vaccination efforts. Incarcerated individuals are at high risk for Covid-19 transmission and severe disease.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.